Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial

Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The changes appear to be minor UI/layout updates with no impact on core study information such as eligibility and outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:32:55.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    23 days ago
    Change Detected
    Summary
    No significant changes detected. The page remains as before; no additions or deletions to core content, names, prices, stock, or time-sensitive details were identified.
    Difference
    0.6%
    Check dated 2025-10-13T11:55:30.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now includes a government-status notice and headers indicating a new version (v3.2.0), replacing the previous v3.1.0.
    Difference
    5%
    Check dated 2025-10-06T07:54:05.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.7%
    Check dated 2025-09-29T04:14:51.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    No significant changes detected.
    Difference
    0.6%
    Check dated 2025-09-22T00:41:04.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-14T22:12:06.000Z thumbnail image

Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.